Esophageal Cancer Risk Rises Alongside Weight

This article originally appeared here.
Share this content:
Esophageal Cancer Risk Rises Alongside Weight
Esophageal Cancer Risk Rises Alongside Weight

WEDNESDAY, March 15, 2017 (HealthDay News) -- Overweight young adults may have a significantly increased risk of esophageal adenocarcinoma (EA) and gastric cardia adenocarcinoma (GCA) if they become obese later in life, according to a study published online Feb. 14 in the British Journal of Cancer.

The research indicated that individuals who were overweight in their 20s had a 60 to 80 percent increased risk of developing EA and GCA, compared with those who maintained a normal weight throughout their life. And those who then gained more than 40 pounds by age 50 doubled their risk of EA and moderately increased their risk for GCA.

However, the researchers found that it was those individuals who progressed from overweight at age 20 to obese at age 50 who had the highest increase in risk for EA (hazard ratio, 2.90) and GCA (hazard ratio, 4.07).

"Being overweight in early adulthood and weight gain later in life were each associated with increased risks of EA and GCA," the authors write. "This underscores the potential of weight control programs for reducing EA and GCA risk."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Mortality Risks of Exclusive Cigar, Cigarette, Pipe Use ID'd

Mortality Risks of Exclusive Cigar, Cigarette, Pipe Use ...

Higher risk of tobacco-related cancer death for current/former cigarette, current cigar, pipe smoking

Burnout Found Prevalent Among Doctors in Single Health System

Burnout Found Prevalent Among Doctors in Single Health ...

Link between patient satisfaction and emotional exhaustion; also tied to odds of leaving organization

Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas

Ulipristal Achieves Amenorrhea for Symptomatic Leiomyomas

Ulipristal superior to placebo to achieve amenorrhea for bleeding due to symptomatic uterine leiomyomas

is free, fast, and customized just for you!

Already a member?

Sign In Now »